Silexion Therapeutics Ltd. (SLXN) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $280,482, listed on NASDAQ, employing roughly 11 people, carrying a beta of -0.29 to the broader market. Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. Led by Ilan Hadar, public since 2024-08-16.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for SLXN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →